Nakano M - Search Results

1

Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol.

Wiek C, Schmidt EM, Roellecke K, Freund M, Nakano M, Kelly EJ, Kaisers W, Yarov-Yarovoy V, Kramm CM, Rettie AE, Hanenberg H. Wiek C, et al. Among authors: nakano m. Biochem J. 2015 Jan 1;465(1):103-14. doi: 10.1042/BJ20140813. Biochem J. 2015. PMID: 25247810 Free PMC article.

2

Sites of covalent attachment of CYP4 enzymes to heme: evidence for microheterogeneity of P450 heme orientation.

Baer BR, Schuman JT, Campbell AP, Cheesman MJ, Nakano M, Moguilevsky N, Kunze KL, Rettie AE. Baer BR, et al. Among authors: nakano m. Biochemistry. 2005 Oct 25;44(42):13914-20. doi: 10.1021/bi051267j. Biochemistry. 2005. PMID: 16229480

3

Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase.

Nakano M, Kelly EJ, Rettie AE. Nakano M, et al. Drug Metab Dispos. 2009 Nov;37(11):2119-22. doi: 10.1124/dmd.109.028530. Epub 2009 Aug 6. Drug Metab Dispos. 2009. PMID: 19661213 Free PMC article.

4

CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant.

Nakano M, Kelly EJ, Wiek C, Hanenberg H, Rettie AE. Nakano M, et al. Mol Pharmacol. 2012 Oct;82(4):679-86. doi: 10.1124/mol.112.080085. Epub 2012 Jul 6. Mol Pharmacol. 2012. PMID: 22772592 Free PMC article.

5

Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.

Nakano M, Lockhart CM, Kelly EJ, Rettie AE. Nakano M, et al. Drug Metab Rev. 2014 Aug;46(3):247-60. doi: 10.3109/03602532.2014.921190. Epub 2014 May 26. Drug Metab Rev. 2014. PMID: 24856391 Free PMC article. Review.

6

Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states.

Kelly EJ, Nakano M, Rohatgi P, Yarov-Yarovoy V, Rettie AE. Kelly EJ, et al. Among authors: nakano m. Mol Interv. 2011 Apr;11(2):124-32. doi: 10.1124/mi.11.2.10. Mol Interv. 2011. PMID: 21540472 Free PMC article. Review.

7

Generation and characterization of a murine model of Bietti crystalline dystrophy.

Lockhart CM, Nakano M, Rettie AE, Kelly EJ. Lockhart CM, et al. Among authors: nakano m. Invest Ophthalmol Vis Sci. 2014 Aug 12;55(9):5572-81. doi: 10.1167/iovs.13-13717. Invest Ophthalmol Vis Sci. 2014. PMID: 25118264 Free PMC article.

8

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.

McDonald MG, Rieder MJ, Nakano M, Hsia CK, Rettie AE. McDonald MG, et al. Among authors: nakano m. Mol Pharmacol. 2009 Jun;75(6):1337-46. doi: 10.1124/mol.109.054833. Epub 2009 Mar 18. Mol Pharmacol. 2009. PMID: 19297519 Free PMC article.

9

Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions.

Huang W, Nakano M, Sager J, Ragueneau-Majlessi I, Isoherranen N. Huang W, et al. Among authors: nakano m. Drug Metab Dispos. 2017 Nov;45(11):1156-1165. doi: 10.1124/dmd.117.076455. Epub 2017 Aug 31. Drug Metab Dispos. 2017. PMID: 28860113 Free PMC article.

10

Probiotic viability in the gastrointestinal tract in a randomised placebo controlled trial: combining molecular biology and novel cultivation techniques.

Sen A, Kimura M, Ejima R, Arai S, Mitsuyama E, Kaneko H, Mishima R, Muto N, Hiraku A, Kato K, Kuwano Y, Maruyama H, Nakamura M, Iwabuchi N, Nakano M, Odamaki T, Tanaka M. Sen A, et al. Among authors: nakano m. Benef Microbes. 2025 Jan 7:1-10. doi: 10.1163/18762891-bja00055. Online ahead of print. Benef Microbes. 2025. PMID: 39814039

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,412 results

Search Page

Filters